Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.

Leonetti A, Boyd L, Giuliani J, Giovannetti E, Garajová I.

Expert Rev Clin Pharmacol. 2019 Nov;12(11):1033-1036. doi: 10.1080/17512433.2019.1683446. Epub 2019 Oct 30. Review.

PMID:
31633383
2.

Immune-checkpoint inhibitors in head and neck squamous cell carcinoma: cost-efficacy in second-line treatment based on programmed death-ligand 1 (PD-L1) level.

Giuliani J, Bonetti A.

Oral Oncol. 2019 Oct;97:143-145. doi: 10.1016/j.oraloncology.2019.08.010. Epub 2019 Aug 17. No abstract available.

PMID:
31431352
3.

The exposure to perfluoroalkyl substances (PFAS) and the development of cancer.

Giuliani J, Bonetti A.

Recenti Prog Med. 2019 Jul-Aug;110(7):368-370. doi: 10.1701/3197.31750. Italian. No abstract available.

PMID:
31379373
4.

Netupitant plus palonosetron is a cost-effective treatment for the prophylaxis of chemotherapy-induced nausea and vomiting in highly and moderately emetogenic cancer treatment.

Giuliani J, Bonetti A.

Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):505-508. doi: 10.1080/14737167.2019.1650644. Epub 2019 Aug 4.

PMID:
31379219
5.

The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab.

Giuliani J, Bonetti A.

Anticancer Res. 2019 Jul;39(7):3971-3973. doi: 10.21873/anticanres.13552.

PMID:
31262930
6.
7.

Financial Toxicity and Non-small Cell Lung Cancer Treatment: The Optimization in the Choice of Immune Check Point Inhibitors.

Giuliani J, Bonetti A.

Anticancer Res. 2019 Jul;39(7):3961-3965. doi: 10.21873/anticanres.13550. Review.

PMID:
31262928
8.

Economic sustainability of nivolumab at flat dose for second-line treatment of metastatic non-small cell lung cancer in real life.

Giuliani J, Albanese V, Ponturo G, Bonetti A.

J Oncol Pharm Pract. 2019 Dec;25(8):2059-2060. doi: 10.1177/1078155219854125. Epub 2019 Jun 10. No abstract available.

PMID:
31181991
9.

Immunotherapy in first-line for advanced non-small cell lung cancer: <br>a cost-effective choice?

Giuliani J, Bonetti A.

Recenti Prog Med. 2019 Mar;110(3):138-143. doi: 10.1701/3132.31141.

PMID:
30968854
10.
11.

Effects of a Preembedded Axial Magnetic Field on the Current Distribution in a Z-Pinch Implosion.

Mikitchuk D, Cvejić M, Doron R, Kroupp E, Stollberg C, Maron Y, Velikovich AL, Ouart ND, Giuliani JL, Mehlhorn TA, Yu EP, Fruchtman A.

Phys Rev Lett. 2019 Feb 1;122(4):045001. doi: 10.1103/PhysRevLett.122.045001.

PMID:
30768289
12.

FOLFIRINOX is a cost-effective combination chemotherapy in first-line for advanced pancreatic Cancer.

Giuliani J, Bonetti A.

Pancreatology. 2019 Mar;19(2):325-330. doi: 10.1016/j.pan.2019.01.014. Epub 2019 Jan 19.

PMID:
30704852
13.

Self-Similar Interfacial Impedance of Electrodes in High Conductivity Media: II. Disk Electrodes.

Koklu A, Mansoorifar A, Giuliani J, Monton C, Beskok A.

Anal Chem. 2019 Feb 5;91(3):2455-2463. doi: 10.1021/acs.analchem.8b05275. Epub 2019 Jan 9.

PMID:
30582795
14.

Colonic Ewing Sarcoma/PNET associated with liver metastases: A systematic review and case report.

Parcesepe P, Giordano G, Zanella C, Giuliani J, Greco F, Bonetti A, Pancione M, Manfrin E, Molinari E, Latiano TP, D'Andrea MR, Fassan M, Olivieri N, Remo A.

Pathol Res Pract. 2019 Feb;215(2):387-391. doi: 10.1016/j.prp.2018.11.021. Epub 2018 Nov 29.

PMID:
30553605
15.

Cost-Effectiveness of Second-Line Treatments for Metastatic Renal-Cell Carcinoma.

Giuliani J, Bonetti A.

Clin Genitourin Cancer. 2019 Apr;17(2):e258-e262. doi: 10.1016/j.clgc.2018.11.010. Epub 2018 Nov 22.

PMID:
30545674
16.

Which grade is of clinical benefit in the randomised controlled trials? The example of 54th American Society of Clinical Oncology annual meeting, 2018.

Giuliani J, Bonetti A.

Eur J Cancer. 2018 Nov;104:233-235. doi: 10.1016/j.ejca.2018.08.026. Epub 2018 Oct 11. No abstract available.

PMID:
30318320
17.

First-line therapies in metastatic colorectal cancer: integrating clinical benefit with the costs of drugs.

Giuliani J, Bonetti A.

Int J Colorectal Dis. 2018 Nov;33(11):1505-1516. doi: 10.1007/s00384-018-3158-8. Epub 2018 Sep 8. Review.

PMID:
30196427
18.

Solution of the Noh problem with an arbitrary equation of state.

Velikovich AL, Giuliani JL.

Phys Rev E. 2018 Jul;98(1-1):013105. doi: 10.1103/PhysRevE.98.013105.

PMID:
30110797
19.

The West Point Knot: A Sliding-Locking Arthroscopic Knot.

Wolfe JA, Pickett AM, Van Blarcum G, Owens BD, Giuliani J, Posner M, Dickens JF.

Arthrosc Tech. 2018 Jun 4;7(7):e685-e689. doi: 10.1016/j.eats.2018.03.001. eCollection 2018 Jul.

20.

Long-term survival in advanced pancreatic cancer.

Giuliani J, Bonetti A.

Recenti Prog Med. 2018 Jun;109(6):352-358. doi: 10.1701/2932.29492. No abstract available.

PMID:
29968866
21.

Anti-angiogenic agents in second-line treatment for metastatic colorectal cancer: the optimization of pharmacological costs.

Giuliani J, Bonetti A.

Int J Colorectal Dis. 2018 Oct;33(10):1487-1491. doi: 10.1007/s00384-018-3077-8. Epub 2018 May 26.

PMID:
29804191
22.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

23.

Regorafenib or Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer? A Perspective on the Basis of Pharmacological Costs.

Giuliani J, Bonetti A.

Clin Colorectal Cancer. 2018 Jun;17(2):e381-e383. doi: 10.1016/j.clcc.2018.02.009. Epub 2018 Feb 23. No abstract available.

PMID:
29550155
24.

Nivolumab Is a Cost-Effective Second-Line Treatment for Metastatic Renal-Cell Carcinoma.

Giuliani J, Bonetti A.

Clin Genitourin Cancer. 2018 Jun;16(3):e557-e562. doi: 10.1016/j.clgc.2018.02.006. Epub 2018 Feb 22.

PMID:
29534940
25.

In-situ magnetization/heating electron holography to study the magnetic ordering in arrays of nickel metallic nanowires.

Ortega E, Santiago U, Giuliani JG, Monton C, Ponce A.

AIP Adv. 2018 Jan 9;8(5):056813. doi: 10.1063/1.5007671. eCollection 2018 May.

26.
27.

The role of ethyl acrylate induced GSH depletion in the rodent forestomach and its impact on MTD and in vivo genotoxicity in developing an adverse outcome pathway (AOP).

Ellis-Hutchings R, Giuliani J, Hayashi M, Masumori S, McClymont EL, Murphy S, Wiench K.

Regul Toxicol Pharmacol. 2018 Feb;92:173-181. doi: 10.1016/j.yrtph.2017.11.012. Epub 2017 Dec 2.

29.

The Pharmacological Costs of Second-Line Treatments for Recurrent Ovarian Cancer.

Giuliani J, Bonetti A.

Int J Gynecol Cancer. 2017 Nov;27(9):1872-1876. doi: 10.1097/IGC.0000000000001106.

PMID:
28976446
30.

Emission enhancement through Nd3+-Yb3+ energy transfer in multifunctional NaGdF4 nanocrystals.

Pedraza FJ, Rightsell C, Kumar GA, Giuliani J, Monton C, Sardar DK.

Appl Phys Lett. 2017 May 29;110(22):223107. doi: 10.1063/1.4984140. Epub 2017 May 31.

31.

Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs.

Giuliani J, Bonetti A.

Expert Rev Pharmacoecon Outcomes Res. 2017 Jun;17(3):243-248. doi: 10.1080/14737167.2017.1347504. Epub 2017 Jul 3.

PMID:
28649886
32.
33.

Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.

Giuliani J, Bonetti A.

Clin Lung Cancer. 2017 Sep;18(5):e363-e365. doi: 10.1016/j.cllc.2017.04.007. Epub 2017 Apr 23. No abstract available.

PMID:
28502555
34.

Recurrent Shoulder Instability in a Young, Active, Military Population and Its Professional Implications.

Flint JH, Pickett A, Owens BD, Svoboda SJ, Peck KY, Cameron KL, Biery J, Giuliani J, Rue JP.

Sports Health. 2018 Jan/Feb;10(1):54-59. doi: 10.1177/1941738117707177. Epub 2017 May 11.

35.

Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.

Giuliani J, Bonetti A.

Recenti Prog Med. 2017 Mar;108(3):152-154. doi: 10.1701/2656.27239. No abstract available.

PMID:
28398410
36.

Use of pyrolyzed paper as disposable substrates for voltammetric determination of trace metals.

Silva LAJ, da Silva WP, Giuliani JG, Canobre SC, Garcia CD, Munoz RAA, Richter EM.

Talanta. 2017 Apr 1;165:33-38. doi: 10.1016/j.talanta.2016.12.009. Epub 2016 Dec 6.

38.

The Pharmacological Costs for the Management of Skin Toxicity in Patients With Cancer Treated With Epidermal Growth Factor Receptor-Inhibitors.

Giuliani J, Bonetti A.

Clin Lung Cancer. 2016 Nov;17(6):471-473. doi: 10.1016/j.cllc.2016.04.006. Epub 2016 May 5. No abstract available.

PMID:
27245292
39.

The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients treated with targeted agents.

Giuliani J, Bonetti A.

Recenti Prog Med. 2016 Aug;107(8):434-9. doi: 10.1701/2332.25068.

PMID:
27571559
40.

The Pharmacological Costs of First-Line Therapies in Unselected Patients With Advanced Colorectal Cancer: A Review of Published Phase III Trials.

Giuliani J, Bonetti A.

Clin Colorectal Cancer. 2016 Dec;15(4):277-284. doi: 10.1016/j.clcc.2016.07.002. Epub 2016 Jul 19. Review.

PMID:
27521066
42.

Development and Characterization of Carbon Based Electrodes from Pyrolyzed Paper for Biosensing Applications.

Giuliani JG, Benavidez TE, Duran GM, Vinogradova E, Rios A, Garcia CD.

J Electroanal Chem (Lausanne). 2016 Mar 15;765:8-15. Epub 2015 Aug 16.

43.

The development of hypertension in metastatic colorectal cancer patients treated with aflibercept: the role of systolic and diastolic blood pressure before starting treatment.

Giuliani J, Bonetti A.

Recenti Prog Med. 2016 Apr;107(4):199-200. doi: 10.1701/2218.23934. No abstract available.

PMID:
27093330
44.

Incidence Rate and Results of the Surgical Treatment of Pectoralis Major Tendon Ruptures in Active-Duty Military Personnel.

Balazs GC, Brelin AM, Donohue MA, Dworak TC, Rue JP, Giuliani JR, Dickens JF.

Am J Sports Med. 2016 Jul;44(7):1837-43. doi: 10.1177/0363546516637177. Epub 2016 Apr 1.

PMID:
27037284
45.

Case Report of a Well-Differentiated Papillary Mesothelioma of the Tunica Vaginalis in an Undescended Testis With Review of Literature.

Parcesepe P, Sina S, Zanella C, Pancione M, Giuliani J, Detogni P, Curti P, Bonetti A, Manfrin E, Remo A.

Int J Surg Pathol. 2016 Aug;24(5):443-7. doi: 10.1177/1066896916628279. Epub 2016 Feb 12. Review.

PMID:
26873338
46.

The role of palliative surgery in the management of advanced pancreatic cancer in patients with biliary and duodenal obstruction.

Giuliani J, Bonetti A.

Eur J Surg Oncol. 2016 Apr;42(4):581-3. doi: 10.1016/j.ejso.2015.12.015. Epub 2016 Jan 29. No abstract available.

PMID:
26868166
47.

Synthesis of CuNP-Modified Carbon Electrodes Obtained by Pyrolysis of Paper.

Duran GM, Benavidez TE, Giuliani JG, Rios A, Garcia CD.

Sens Actuators B Chem. 2016 May;227:626-633.

48.

[Platinum antitumor complexes].

Bonetti A, Giuliani J, Muggia F.

Recenti Prog Med. 2015 Dec;106(12):618-28. doi: 10.1701/2094.22652. Review. Italian.

PMID:
26780071
49.
50.

Second-Line Treatment in Elderly Patients With Advanced Non-Small-Cell Lung Cancer.

Giuliani J, Bonetti A.

Clin Lung Cancer. 2016 Mar;17(2):e25-7. doi: 10.1016/j.cllc.2015.10.003. Epub 2015 Nov 10. No abstract available.

PMID:
26700909

Supplemental Content

Loading ...
Support Center